RFX5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.645000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.962400E-01
Normal-vs-Stage2
2.699400E-01
Normal-vs-Stage3
1.997190E-01
Normal-vs-Stage4
1.721440E-01
Stage1-vs-Stage2
6.565600E-01
Stage1-vs-Stage3
5.443700E-02
Stage1-vs-Stage4
9.420200E-01
Stage2-vs-Stage3
1.345830E-01
Stage2-vs-Stage4
7.818200E-01
Stage3-vs-Stage4
1.933420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.631000E-01
Normal-vs-AfricanAmerican
3.079800E-01
Normal-vs-Asian
2.713200E-01
Caucasian-vs-AfricanAmerican
4.437000E-01
Caucasian-vs-Asian
8.875000E-01
AfricanAmerican-vs-Asian
5.787400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.542800E-01
Normal-vs-Female
2.782400E-01
Male-vs-Female
1.549620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.490000E-01
Normal-vs-Age(41-60Yrs)
2.724200E-01
Normal-vs-Age(61-80Yrs)
2.625600E-01
Normal-vs-Age(81-100Yrs)
2.555200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.409800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.195800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.472000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.774600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.396000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.257000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.415200E-01
Normal-vs-Daily Drinker
2.450800E-01
Normal-vs-Weekly Drinker
2.687400E-01
Normal-vs-Occasional Drinker
2.610800E-01
Normal-vs-Social Drinker
2.673000E-01
Non Drinker-vs-Daily Drinker
9.043200E-01
Non Drinker-vs-Weekly Drinker
4.266000E-01
Non Drinker-vs-Occasional Drinker
5.155400E-01
Non Drinker-vs-Social Drinker
3.778600E-01
Daily Drinker-vs-Weekly Drinker
5.072400E-01
Daily Drinker-vs-Occasional Drinker
6.094200E-01
Daily Drinker-vs-Social Drinker
4.539800E-01
Weekly Drinker-vs-Occasional Drinker
8.482600E-01
Weekly Drinker-vs-Social Drinker
9.981200E-01
Occasional Drinker-vs-Social Drinker
8.270800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.894200E-01
Normal-vs-Grade 2
9.935700E-02
Normal-vs-Grade 3
2.309600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.695630E-01
Grade 1-vs-Grade 3
4.155400E-01
Grade 1-vs-Grade 4
4.894200E-01
Grade 2-vs-Grade 3
3.860800E-01
Grade 2-vs-Grade 4
9.935700E-02
Grade 3-vs-Grade 4
2.309600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.503800E-01
Normal-vs-NonDiabetic
2.550000E-01
Diabetic-vs-NonDiabetic
7.444200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.019800E-01
Normal-vs-NoPancreatitis
2.528800E-01
Pancreatitis-vs-NoPancreatitis
1.193780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.733200E-01
Normal-vs-N1
2.637600E-01
N0-vs-N1
6.350000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.076800E-01
Normal-vs-TP53-NonMutant
2.967400E-01
TP53-Mutant-vs-TP53-NonMutant
6.982600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
